Human melanoma cells do not express Fas (Apo-1/CD95) ligand
about
Natural selection of tumor variants in the generation of "tumor escape" phenotypesTumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancerFas ligand expression in human and mouse cancer cell lines; a caveat on over-reliance on mRNA data.Cancer therapy using a self-replicating RNA vaccineAnalysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.Immunosuppressive strategies that are mediated by tumor cellsFas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden.Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumorsBuilding better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunityThe role of MHC class I glycoproteins in the regulation of induction of cell death in immunocytes by malignant melanoma cells.Assumptions of the tumor 'escape' hypothesis.Mutational and functional analysis reveals ADAMTS18 metalloproteinase as a novel driver in melanoma.Cancer vaccines: progress reveals new complexities.Mammal cells double their total RNAs against diabetes, ischemia reperfusion and malaria-induced oxidative stress.Developing recombinant and synthetic vaccines for the treatment of melanoma.Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibitionExpression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.Frequent mutations in the MITF pathway in melanomaDual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.Cytomegalovirus and tumors: two players for one goal-immune escape.
P2860
Q24551158-9EE6F2AD-5159-4500-B0A6-8BEFF499C901Q24801183-9346B7B2-ECD9-4450-A728-7D2A71AA69E3Q25256768-BC78A4FF-A9C6-4B10-A268-B994161861ADQ27481056-68DE7118-630E-46D5-8090-406651D62C91Q27851483-4C70599F-558B-42BD-AAD6-55B61BA96ECFQ29636247-5B2899C7-BF42-44A5-B027-04459DBAED4CQ33530092-2DC11C01-26AA-4348-8B28-4097125D8BF5Q33765767-6594E5E5-BA71-4162-9400-5C386945226EQ34046869-108787F2-FCE1-42D8-A793-A64A93FCFC85Q34100958-9294BAD4-981F-4B12-B81E-86B3FCCCC26BQ34583258-53FA623D-5C5A-4D3A-979C-DB48E3CAE26FQ34682013-7AC0DC0F-BBFD-4CFC-921D-6A60A9B5D0C3Q34774541-611DCD69-2E6D-4B49-8E17-8F38AFF02DB2Q35017002-6111ACA2-CEF5-4646-AB77-88F3E562150EQ35946196-397B78A3-3E88-4520-A4F7-818D75D9E973Q35956638-33E3B8EB-5548-4769-8C10-B3D09709E3F2Q36432026-4A8BADDA-00F5-4F24-849B-24E95E1F41B2Q36454475-5D1A85FD-0A2D-4782-9129-90E3C116A467Q36471604-1EBD3435-2D57-46C4-ACCE-A9D61B4B2C06Q36621610-BDC012C3-F9E0-44E7-AD77-65E1D9BAFD63Q36648740-BAE1636D-7D13-4671-9012-AC2E1CF6F3A5Q36860110-813BE721-5E96-4E6D-ADA2-2948BF1C6140Q37309027-25D695B3-ACC6-4D4D-8CFA-B5ED46993A8AQ40314772-C97C1426-CB69-49A3-BBBE-5298C7F1EB68Q42144694-402274F2-C646-4DEA-983B-7A60CE7BB089
P2860
Human melanoma cells do not express Fas (Apo-1/CD95) ligand
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Human melanoma cells do not express Fas (Apo-1/CD95) ligand
@ast
Human melanoma cells do not express Fas (Apo-1/CD95) ligand
@en
type
label
Human melanoma cells do not express Fas (Apo-1/CD95) ligand
@ast
Human melanoma cells do not express Fas (Apo-1/CD95) ligand
@en
prefLabel
Human melanoma cells do not express Fas (Apo-1/CD95) ligand
@ast
Human melanoma cells do not express Fas (Apo-1/CD95) ligand
@en
P2093
P2860
P1433
P1476
Human melanoma cells do not express Fas (Apo-1/CD95) ligand
@en
P2093
D B Chappell
N P Restifo
S A Rosenberg
P2860
P407
P577
1999-01-01T00:00:00Z